Peer Reviewer	Representation	Consultant	Speaker	Ownership/ Partnership/ Principal	Research	Institutional, Organizational or Other Financial Benefit	Expert Witness
Mazen Abu-Fadel	Content Reviewer- ACC Councils and Sections	None	Abbott Vascular	None	None	None	None
Cynthia Arslanian- Engoren	Content Reviewer- AHA Committee: CV and Stroke Nursing Council	None	None	None	None	None	None
Brian Carlin	Official Reviewer- AACVPR	Glaxo Smith Kline, Respironics, Forest, Breathe Technologies, Boehringer-Ingelheim †	None	None	None	National Board for Respiratory Care* National Lung Health Education Program*	None
Lola Coke	Official Reviewer- ANA	None	None	None	None	None	None
Eileen Collins	Official Reviewer- AACVPR	None	None	None	None	None	None
Silvana Lawrence	Content Reviewer- ACC Councils and Sections	None	None	None	None	None	None
Maulik D. Majmudar,	Content reviewer- ACC Patient-Centered Care Committee	None	None	None	None	None	None
Ariane Marelli	Content Reviewer- ACC Councils and Sections	None	None	None	None	None	None
Robert Piana	Content Reviewer- ACC Councils and Sections	W.L. Gore & Associates, Inc. HCRI Axio Research	None	None	Amplatzer Corporation	Vascutek	2012: Third Party Quality Review 2012: Defendant-Interventional Cardiology 2011: Defendant CAD Management 2011 Defendant: Interventional Cardiology
Sara Paul	Content Reviewer- AHA Committee: CV and Stroke Nursing Council	None	None	None	None	Heart Failure Society of America*	None
Susan Pressler	Content Reviewer- AHA Committee: CV and Stroke Nursing Council	None	None	None	None	Pfizer* NIH †	None
Michael Rich	Content Reviewer- ACC Councils and Sections	None	None	None	None	None	None
Barbara Riegel	Official Reviewer- AHA	None	None	None	None	NIH AHA*	None
William Roach	Official Reviewer- AHA	None	None	None	None	AHA*	None
Darryl Roberts	Official Reviewer- ANA	None	None	None	None	None	None
Joachim Roski	Official Reviewer- AMA-PCPI	None	None	None	None	None	None
Amy Schneider	Official Reviewer- AAFP	None	None	None	None	None	None
Chittur Sivaram	Content Reviewer- ACC Councils and Sections	Medtronic	None	None	None	None	None
Karen Walker	Content Reviewer- ACC Councils and Sections	None	None	None	None	None	None
Minnow Walsh	Content Reviewer- ACC CQC Committee and ACC Patient-Centered Care Committee	Eli Lilly Novartis United HealthCare	None	None	None	None	None

This table represents the relevant relationships with industry and other entities that were disclosed at the time of peer review. It does not necessarily reflect relationships with industry at the time of publication. A person is deemed to have a significant interest in a business if the interest represents ownership of 5% or more of the voting stock or share of the business entity, or ownership of $10 000 or more of the fair market value of the business entity, or if funds received by the person from the business entity exceed 5% of the person's gross income for the previous year. A relationship is considered to be modest if it is less than significant under the preceding definition. Relationships that exist with no financial benefit are also included for the purposes of transparency. Relationships in this table are modest unless otherwise noted.

AACVPR indicates American Association of Cardiovascular and Pulmonary Rehabilitation; AAFP, American Academy of Family Physicians; ACC, American College of Cardiology; AHA, American Heart Association; AMA-PCPI, American Medical Association–Physician Consortium for Performance Improvement; ANA, American Nurses Association; ASHP, American Society of Health-System Pharmacists; CQC: Clinical Quality Committee; NCQA, National Committee for Quality Assurance; NIH, National Institute of Health.